Top 10 Life Sciences Stocks To Own For 2014

Another week of new all-time highs for the Dow Jones Industrial Average coupled with a good start to earnings season has given optimists little reason to fret. For skeptics like me, that's an opportunity to see whether companies have earned their current valuations.

Keep in mind that some companies�deserve�their current valuations. Life sciences company Life Technologies�jumped to new highs this week following word that Thermo Fisher Scientific�will make a bid for the company, and that other private-equity firms are finalizing their bids.�With Life Technologies having publicly announced a strategic review in January, it seems like a long-awaited buyout could be right around the corner for shareholders.

Still, other companies might deserve a kick in the pants. Here's a look at three companies that could be worth selling.

Leave the wrapper on
The returns on confectioner Tootsie Roll Industries (NYSE: TR  ) have certainly been sweet for investors over the past year. You have to go back to the summer of 2010 to find sugar prices that were as low as they are now,�which has played a good part in helping Tootsie Roll keep that aspect of its costs down. But taking a bigger view of what's going on with Tootsie Roll and comparing that to its current valuation creates a sour taste in my mouth.

Top Trucking Stocks For 2015: LCY Chemical Corp (1704.TW)

LCY Chemical Corporation is principally engaged in the manufacture and distribution of polypropylene (PP), solvents and other chemical products. The Company provides methanol products, including methanol, formaldehyde, paraformaldehyde and dimethyl ether, among others; solvents, including ethyl acetate, isopropyl alcohol and methyl isobutyl ketone, as well as electronic chemical products, PP related products, thermoplastic rubber and liquefied petroleum gas (LPG). Its products are applied in the manufacture of resins, agricultural pesticides, catalysts, medicines, paintings, inks, artificial leather products, shoes, industrial products, electronic components, toys and electrical appliances, among others. On June 23, 2014, it acquired a certain shares of TECHNOLOGY CORP. After that, it holds 86.65% stake of LCY TECHNOLOGY CORP. Advisors' Opinion:

• [By Anna Prior]

  Kraton Performance Polymers Inc.'s(KRA) board is no longer pushing for the company’s stockholders to approve its plans to combine with LCY Chemical Corp.'s(1704.TW) styrenic block copolymer operations.

Top 10 Life Sciences Stocks To Own For 2014: EP Energy Corp (EPE)

EP Energy Corporation, incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company is focused on creating shareholder value through the development of its low-risk drilling inventory located in four core areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont field in the Uinta Basin in northeastern Utah and the Haynesville Shale (North Louisiana). In its core areas, it has identified approximately 5,200 drilling locations (including 916 drilling locations to which it has attributed proved undeveloped reserves as of September 30, 2013), of which approximately 96% are oil wells. As of September 30, 2013, it had proved reserves of 513 million barrels of oil equivalent (54% oil and 67% liquids) and for the three months ended September 30, 2013, it had average net daily production of 88,149 barrels of oil equivalent per day (45% oil and 54% liquids). During the year ending September 31, 2013, it sold certain of its natural gas properties, including CBM properties located in the Raton, Black Warrior and Arkoma basins, the majority of its Arklatex natural gas properties and its natural gas properties in South Texas. In May 2014, the Company acquired certain producing properties and undeveloped acreage directly offsetting existing Wolfcamp operating areas in Reagan and Crockett Counties in the Southern Midland Basin.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is the unconventional oil plays in the United States. The Eagle Ford formation in La Salle County has up to 125 feet of net thickness, making it some of the prolific acreage in the area. Due to its high carbonate content, the Eagle Ford is also brittle, and delivers high productivity when fractured, with initial 30-day oil equivalent production rates up to 1,100 barrels of oil equivalent! per day.. The Company as of september 30, 2013, has 97,689 net acres in the Eagle Ford, where it has identified 983 drilling locations. As of September 30, 2013, it had six rigs running and it plan to drill 126 wells in 2013 (of which 100 have been drilled through September 30, 2013), representing 58% of its total wells planned in 2013.

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin, which has produced more than 29 billion barrels of oil and 75 trillion cubic feet of gas over the past 90 years and is estimated by industry experts to contain recoverable oil and natural gas reserves exceeding what has already been produced. With oil production of over 880 one thousand barrels per day from over 80,000 wells during the six months ended June 30, 2013, the Permian Basin represented 51% of the crude oil produced in the State of Texas and approximately 17% of the crude oil and condensate produced onshore in the lower 48 United States. As of September 30, 2013, it had three rigs running and it plans to drill 65 wells in 2013 (of which 48 have been drilled through September 30, 2013), representing 30% of its total wells planned in 2013.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. Its operations are primarily focused on developing the Altamont Field Complex (comprised of the Altamont, Bluebell and Cedar Rim fields). It owns 170,523 net (315,272 gross) acres in Duchesne and Uinta Counties, making it the ease owner in the Altamont Field Complex. Its activity is mainly focused on the development of its vertical inventory on 160-acre spacing. The Company has identified an inventory of 1,135 drilling locations (781 vertical and 354 horizontal). The industry is piloting 80-acre vertical downspacing programs in the Wasatch and Green River formations and horizontal development programs in the multiple shale and tight sand intervals. As of September 30, 2013, it had two rigs running and it plans to drill 26 wells in ! 2013 (of w! hich 20 have been drilled through September 30, 2013), representing 12% of its total wells planned in 2013.

Haynesville Shale

Haynesville Shale is located in East Texas and Northern Louisiana. its operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. This area is within the core of the Haynesville Shale with net thickness of 114 feet (210 feet gross), resulting in initial 30-day gas equivalent production rates up to 18 million cubic feet per day. As of September 30, 2013, it has identified 190 drilling locations.

Advisors' Opinion:

• [By Matt Jarzemsky var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Rice Energy Inc.(RICE) has rallied 44% since its $1.1 billion January IPO through Thursday. RSP Permian Inc.(RSPP) has gained 42% since debuting the same month. This year�� other E&P IPO, EP Energy Corp.(EPE), is off 1.9% since it went public in January.

Top 10 Life Sciences Stocks To Own For 2014: Albemarle Corp (ALB)

Albemarle Corporation (Albemarle), incorporated in 1993, is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets. As of December 31, 2011, the Company and its joint ventures operated 50 facilities, encompassing production, research and development facilities, and administrative and sales offices in North and South America, Europe, the Middle East, Asia, Africa and Australia. It serves approximately 3,000 customers in over 100 countries. It operates in three segments: Polymer Solutions, Catalysts and Fine Chemistry. On May 11, 2011, the Company acquired Catilin Inc. In October 2013, Albemarle Corp acquired Cambridge Chemical Co Ltd.

Polymer Solutions

The Company�� Polymer Solutions segment consists of two product market categories: flame retardants and stabilizers and curatives. Its products include plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, foam insulation, and foam seating in furniture and automobiles. Its brominated flame retardants include products such as Saytex; its mineral-based flame retardants include products, such as Martinal and Magnifin, and its phosphorus-based flame retardants include products, such as Antiblaze and Ncendx.

The Company produces plastic additives, as well as other additives, such as curatives, antioxidants and stabilizers. Its additives products include curatives for polyurethane, polyurea, and epoxy system polymerization. This business also produces antioxidants and stabilizers. Its Ethacure curatives are used in cast elastomers, coatings, reaction injection molding (RIM) and specialty adhesives, which are incorporated into products, such as wheels, tires and rollers. Its line of Ethanox antioxi! dants is used by manufacturers of polyolefins to maintain physical properties during the manufacturing process, including the color of the final product. These antioxidants are found in applications, such as slit film, wire and cable, food packaging and pipes.

The Company produces antioxidants used in fuels and lubricants. Its line of Ethanox fuel and lubricant antioxidants is used by refiners and fuel marketers to extend fuel storage life and protect fuel systems, and by oil marketers and lubricant manufacturers to extend the useful life of lubricating oils, fluids and greases used in engines and various types of machinery. Its polymer solutions segment offers more than 80 products to a range of end-markets. It sells its products to chemical manufacturers and processors, such as polymer resin suppliers, lubricant manufacturers, refiners and other specialty chemical companies.

The Company competes with Chemtura Corporation, Israel Chemicals Ltd, Jiangsu Yoke Technology Co., Ltd., Zhejiang Wansheng Chemical Co., Ltd., J.M. Huber Corporation, Kyowa Chemical Industry Co., Ltd., Nabaltec GmbH, BASF Corporation, Chemtura Corporation and Songwon Industrial Co., Ltd.,

Catalysts

The Company�� Catalysts segment includes its refinery catalysts and catalyst solutions businesses. Its main refinery catalysts product lines are hydroprocessing catalysts (HPC), and fluidized catalytic cracking (FCC), catalysts and additives. HPC catalysts are used to reduce the quantity of sulfur and other impurities in petroleum products, as well as to convert feedstock into lighter products. FCC catalysts assist in the cracking of petroleum streams into derivative, higher-value products, such as fuels and petrochemical feedstock. Its FCC additives are used to remove sulfur in gasoline and to reduce emissions of sulfur dioxide and nitrogen oxide in FCC units. It offers approximately 130 different HPC catalysts products and approximately 40 different FCC catalysts and additives pro! ducts to ! its customers.

The Company has three business units in its performance catalyst solutions (PCS) division: polymer catalysts, chemical catalysts and electronic materials. It manufactures organometallic co-catalysts, as well as metallocene components and co-catalysts. It also offers finished Single-Site catalysts with or without its ActivCat technology and a range of Ziegler-Natta catalysts under the Advantage brand. Its co-catalysts and finished catalysts are used in its customers��production of polyolefin polymers. Such polymers are commodity (Ziegler Natta polymerization technology) and specialty (Single Site polymerization technology) plastics serving a range of end markets, including packaging, non-packaging, films and injection molding. Some of its organometallic products are also used in the manufacture of alpha-olefins (hexene, octane and decene). In electronic materials, it manufacture and sells metal organic products into electronic applications, such as the production of light emitting diodes (LEDs) for displays and general lighting, as well as other products used in the production of solar cells. Its chemical catalysts include a range of catalysts used in the chemical industry.

The Company competes with Criterion Catalysts and Technologies, W.R. Grace & Co./Advanced Refining Technologies, Haldor Topsoe, W.R. Grace & Co., BASF Corporation, AkzoNobel and Chemtura Corporation.

Fine Chemistry

The Company�� Fine Chemistry segment consists of two categories: performance chemicals, and fine chemistry services and intermediates. Performance chemicals include products, such as elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon and a range of bromine fine chemicals. Its products are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing and other industrial applications. Other performance chemicals, wh! ich it pr! oduces include tertiary amines for surfactants, biocides, disinfectants and sanitizers; potassium-based products used in industrial applications; alkenyl succinic anhydride used in paper-sizing formulations, and aluminum oxides used in a range of refractory, ceramic and polishing applications. It sells these products to customers globally for use in personal care products, automotive insulation, foundry bricks and other industrial products.

The Company�� fine chemistry services business offers custom manufacturing, research and chemical scale-up services for companies. Its pharmaceutical bulk active is ibuprofen. Ibuprofen is used to provide pain relief and fever reduction. Bulk ibuprofen is formulated by pharmaceutical companies, which sells in both the prescription and over-the-counter markets. The Company also produces a range of intermediates used in the manufacture of a range of over-the-counter and prescription drugs.

The Company�� agrichemicals are sold to agrichemical manufacturers and distributors, which produce and distribute finished agricultural herbicides, insecticides, fungicides and soil fumigants. Its products include orthoalkylated anilines used in the acetanilide family of pre-emergent herbicides used with corn, soybeans and other crops and methyl bromide, which is used as a soil fumigant. It also manufactures and supplies a range of custom chemical intermediates for the agricultural industry.

The Company competes with Chemtura Corporation, Israel Chemicals, BASF Corporation, Lonza, Clariant Ltd. and Cilag AG.

Advisors' Opinion:

• [By Jayson Derrick]

  Albemarle (NYSE: ALB) has agreed to acquire Rockwood Holdings (NYSE: ROC) for $6.2 billion, or $85.53 per share. The acquisition represents a roughly 13 percent premium to Rockwood Holdings' closing price. The newly formed company will combine two of the world's largest specialty chemical companies. According to Albemarle's CEO Luther Kissam the acquisition will result in a “broader customer reach, increased diversity across end markets, technologies and geographies, and more consistent and predictable earnings growth.” Shares of Albemarle hit new 52-week highs of $76.28 before turning negative and closing the day at $70.03, down 3.57 percent. However, shares of Rockwood Holdings hit new 52-week highs of $86.18 before closing the day at $83.14, up 9.83 percent.

• [By James E. Brumley]

  If you're looking for some trading action, then Organovo Holdings Inc. (NYSEMKT:ONVO) and Albemarle Corporation (NYSE:ALB) are the two top names to put on your radar today. Granted, they're trading candidates for completely opposing reasons. In fact, the best "play" may be to swap one for the other. However you want to play it though, here's what you need to know about ALB and ONVO.

• [By Rich Duprey]

  Specialty chemicals maker�Albemarle (NYSE: ALB  ) announced yesterday its third-quarter dividend of $0.24 per share, the same rate it's paid for the past two quarters after raising the payout 20% from $0.20 per share.

• [By Seth Jayson]

  Albemarle (NYSE: ALB  ) reported earnings on July 17. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Albemarle missed estimates on revenues and met expectations on earnings per share.

Top 10 Life Sciences Stocks To Own For 2014: Universal Truckload Services Inc (UACL)

Universal Truckload Services, Inc., incorporated on December 11, 2001, is engaged in providing transportation services to shippers throughout the United States and in the Canadian provinces of Ontario and Quebec. The Company�� over-the-road trucking services include both flatbed and dry van operations and it provides rail-truck and steamship-truck intermodal support services. It also offers truck brokerage services, as well as full service international freight forwarding and customs house brokerage services. The Company provides truckload transportation and related services for a range of general commodities over irregular routes using dry and specialty vans and un-sided trailers, including flatbed, drop deck, and specialty. In December 2013, the Company announced that it has completed acquisition of Westport Axle Corporation.

The Company primarily operates through a contractor network of agents and owner-operators who provide the Company with approximately 3,100 tractors and approximately 3,000 trailers. At December 31, 2011, the Company had approximately 565 agents. The Company conducts its operations through its wholly owned operating subsidiaries under the brand names, such as Universal Am-Can, Ltd., Mason & Dixon Lines, Inc., Louisiana Transportation Inc., Mason Dixon Intermodal, Inc., Economy Transport, Inc., Great American Lines, Inc., Universal Logistics Solutions, Inc., Universal Logistics Solutions International, Inc. and Cavalry Transportation, LLC.

The Company provides services in three categories, such as truckload services, brokerage services and intermodal support services. The Company transports a range of general commodities, including machinery, building materials, paper, food, consumer goods, automotive parts, furniture, steel and other metals. During the year ended December 31, 2011, its truckload operations represented 60.5%, of its operating revenues.

The Company provides primarily broker freight to third-party transportation providers th! rough its agent network at times when the Company generates more freight business than it can service with its available owner-operators. The Company offers full service international freight forwarding and customs house brokerage services, as well as third-party logistic services. During 2011, its brokerage services represented 24.8%, of its operating revenues. Its intermodal support services are primarily short-to-medium distance delivery of rail and steamship containers between the railhead or port and the customer and drayage services. During 2011, its intermodal support services represented 14.7% of its operating revenues.

The Company�� agents provide the primary interaction with its shippers. They generate freight shipments and also provide terminal and dispatch services for the owner-operators and are an essential source for recruitment of new owner-operators. The agents use a company-provided software program to list available freight procured by the agent, dispatch owner-operators to haul the freight and provide all administrative information necessary for it to establish the credit arrangements for each shipper. The owner-operators are individuals who own, operate and maintain one or more tractors that they either provide drivers, or drive themselves. The Company�� owner-operators provide it with approximately 3,100 tractors. Owner-operators also may own trailers that they provide the Company in addition to their tractor and driving services. As of December 31, 2011, its owner-operators provided approximately 3,000 trailers, which represent over 50% of the trailers the Company use in its business.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Universal Truckload Services (NASDAQ: UACL  ) , a North American provider of trucking and logistics solutions, jumped as much as 12% after receiving an upgrade from BB&T�Capital Markets.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Universal Truckload Services (Nasdaq: UACL  ) , whose recent revenue and earnings are plotted below.

Top 10 Life Sciences Stocks To Own For 2014: PowerShares DB US Dollar Index Bullish Fund (UUP)

PowerShares DB US Dollar Index Bullish Fund (the Fund) is a separate series of PowerShares DB US Dollar Index Trust (the Trust). The Fund�� subsidiary is DB US Dollar Index Bullish Master Fund (the Master Fund), a separate series of DB US Dollar Index Bullish Master Trust (the Master Trust). The Fund offers common units of beneficial interest (the Shares) only to certain eligible financial institutions (the Authorized Participants) in one or more blocks of 200,000 Shares, called a Basket. The proceeds from the offering of Shares are invested in the Master Fund.

The Master Fund invests in futures contracts (the DX Contracts) with a view to tracking the changes, whether positive or negative, in the level of the Deutsche Bank US Dollar Index (USDX) Futures Index - Excess Return (Long Index) (referred to as the Long Index or the Index), over time. The Fund earns interest income from the United States Treasury obligations and other high credit quality short-term, fixed-income securities. The Index is calculated to reflect the changes in market value over time, whether positive or negative, of long positions in DX Contracts. DX Contracts are traded through the currency markets of ICE Futures U.S. under the symbol DX. The changes in market value over time, whether positive or negative, of the DX Contracts are related to the changes, whether positive or negative, in the level of the U.S. Dollar Index (the USDX). The Index provides a general indication of the international value of the United States dollar relative to the six major world currencies (the Index Currencies), which comprise the USDX, including Euro, Japanese Yen, British Pound, Canadian Dollar, Swedish Krona and Swiss Franc.

The Fund, through its Master Fund, establishes long positions in DX Contracts with a view to tracking the changes, whether positive or negative, in the level of the Index. The performance of the Fund also is intended to reflect the excess, if any, of its Master Fund�� interest income from its hol! dings of the United States Treasury obligations and other high credit quality short-term, fixed-income securities over the expenses of the Fund and the Master Fund. DB Commodity Services LLC serves as the managing owner, commodity pool operator and commodity trading advisor of the Fund and the Master Fund. DB Commodity Services LLC is an indirect wholly owned subsidiary of Deutsche Bank AG. The Bank of New York Mellon serves as the administrator of the Fund and the Master Fund.

Advisors' Opinion:

• [By Luke Jacobi]

  After taking a huge hit yesterday, the Dollar was mostly flat to finish out the week. At last check, the Powershares ETF (NYSE: UUP) which tracks the value of the US dollar versus a basket of foreign currencies moved up 0.02 percent to 21.45.

Top 10 Life Sciences Stocks To Own For 2014: XenoPort Inc.(XNPT)

XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing internally discovered product candidates that utilize the body?s natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate Gabapentin Enacarbil, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited in the United States. Astellas Pharma Inc. filed new drug application for the approval of Gabapentin Enacarbil as a treatment for restless legs syndrome in Japan. The company also develops Arbaclofen Placarbil, which completed a Phase II clinical trial for the treatment of spasticity in patients with spinal cord injury. In addition, it develops Arbaclofen Placarbil for the treatment of gastroesophageal reflux disease. Further, the company develops XP21279, which is in Phase II clinical trial for the treatment of Parkinson?s disease; and XP2382 9, a novel prodrug of methylhydrogenfumarate that is in preclinical stage. It has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California.

Advisors' Opinion:

• [By Sean Williams]

  Shareholders of XenoPort (NASDAQ: XNPT  ) are also glad for the long weekend after their stock tumbled this week following disappointing late-stage results for Arbaclofen Placarbil, or AP. Aimed at treating spasticity in patients with multiple sclerosis, AP was unsuccessful in delivering a statistically significant benefit compared to the placebo. XenoPort's management noted that the company plans to cease development of AP and instead focus on the commercial development of recently approved restless leg syndrome drug Horizant, and its remaining clinical pipeline.

• [By Max Macaluso, Ph.D.]

  Treatments for RLS
  While a better understanding of RLS and its long-term impact on health are needed, there are FDA-approved drugs available to treat the symptoms of this disorder. GlaxoSmithKline (NYSE: GSK  ) brought a RLS drug, Requip, to market eight years ago, and the drug was also approved for Parkinson's disease. Total sales of the medication have been falling in recent years due to generic competition and reached only 164 million pounds ($257.5 million) in 2012. Until recently, GSK also had a second RLS drug called Horizant in collaboration with biotech company XenoPort (NASDAQ: XNPT  ) . GSK recently handed the rights to the drug back to XenoPort after sales failed to meet its expectations, and the biotech is now commercializing the drug alone.

• [By Monica Gerson]

  Breaking news

  Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.

  Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By CRWE]

  XenoPort, Inc. (Nasdaq:XNPT) reported that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to begin clinical studies of XP23829 as a potential treatment for relapsing-remitting multiple sclerosis (RRMS).

Top 10 Life Sciences Stocks To Own For 2014: U.S. Physical Therapy Inc.(USPH)

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical and occupational therapy clinics in the United States. Its clinics provide pre-and-post operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company also offers physician services to third parties; and operates clinics, which specialize in the outpatient, non-surgical treatment of osteo arthritis degenerative joint disease and other musculoskeletal conditions. As of December 31, 2011, it operated 416 clinics in 42 states; and managed 15 physical therapy facilities for third parties, including physicians. The company focuses its marketing efforts on physicians comprising orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists, occupational medicine physicians, and general practitioners. U.S. Physical Therapy, Inc. was founded in 1 990 and is based in Houston, Texas.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on US Physical Therapy (NYSE: USPH  ) , whose recent revenue and earnings are plotted below.